Local Injection for the Treatment of Chronic Wounds and Pain Caused by Chronic Wounds
CompletedNot applicableNCT05810649
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Chronic wounds are wounds or ulcers that do not heal properly and are generally classified as venous, arterial, diabetic, traumatic and pressure chronic wounds and is often associated with inflammatory and neuropathic pain. Preliminary clinical studies have confirmed that injection of freshly prepared HA35 promoted the healing of chronic wounds and relieved the pain associated with chronic wounds. This clinical study is a prospective repeated experiments. The purpose of this study was to verify the effectiveness of HA35 injection therapy.
Study details
- Official title
- Local Injection Freshly Manufactured 35kDa Hyaluronan Fragment HA35 for Treatment of Chronic Wounds and Pain Caused by Chronic.
- Conditions
- Pain
- Chronic Wound
- Interventions
- Drug: Freshly manufactured 35 kDa hyaluronan fragment
- Sponsor
- Nakhia Impex LLC
- Start date
- 2023-04-02
- Primary completion
- 2023-08-20
- Sex
- All
- Age range
- from 18 Years to 60 Years
- Results posted
- No results posted in this snapshot
- Countries
- China
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * The chronic wounds of painful diabetic wounds, venous wounds, arterial wounds, traumatic and pressure wounds whichvhad not been closed more than 3 months. * All the chronic wounds were clinically presented by surface darkeness and purulent secretions on the wounds, and darkness or redness, swelling, dryness and broken surface of the skin immediately surrounding the wounds. * Subject agrees to be compliant with study related visit and treatment schedule. * Written informed consent. * Adults aged 18-60 years. Exclusion Criteria: * Have a persistent pain resulted from other medical conditions or unknown causes. * History of wound healing abnormalities or a medical condition that is known to be associated with abnormal wound healing. * Subjects with any known coagulation disorder. * Pregnant females. * Be concomitantly participating in another clinical study.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05810649